163 related articles for article (PubMed ID: 10232408)
1. Squamous cell carcinoma in a family with dominant dystrophic epidermolysis bullosa: a molecular genetic study.
Christiano AM; Crollick J; Pincus S; Uitto J
Exp Dermatol; 1999 Apr; 8(2):146-52. PubMed ID: 10232408
[TBL] [Abstract][Full Text] [Related]
2. Novel glycine substitution mutations in COL7A1 reveal that the Pasini and Cockayne-Touraine variants of dominant dystrophic epidermolysis bullosa are allelic.
Kon A; Nomura K; Pulkkinen L; Sawamura D; Hashimoto I; Uitto J
J Invest Dermatol; 1997 Nov; 109(5):684-7. PubMed ID: 9347800
[TBL] [Abstract][Full Text] [Related]
3. A glycine-to-arginine substitution in the triple-helical domain of type VII collagen in a family with dominant dystrophic epidermolysis bullosa.
Christiano AM; Morricone A; Paradisi M; Angelo C; Mazzanti C; Cavalieri R; Uitto J
J Invest Dermatol; 1995 Mar; 104(3):438-40. PubMed ID: 7861014
[TBL] [Abstract][Full Text] [Related]
4. Identification of the glycine-to-arginine substitution G2043R in type VII collagen in a family with dominant dystrophic epidermolysis bullosa from Hungary.
Cserhalmi-Friedman PB; Karpati S; Horvath A; Christiano AM
Exp Dermatol; 1997 Dec; 6(6):303-7. PubMed ID: 9412818
[TBL] [Abstract][Full Text] [Related]
5. A de novo glycine substitution mutation in the collagenous domain of COL7A1 in dominant dystrophic epidermolysis bullosa.
Lee JY; Li C; Chao SC; Pulkkinen L; Uitto J
Arch Dermatol Res; 2000 Apr; 292(4):159-63. PubMed ID: 10836608
[TBL] [Abstract][Full Text] [Related]
6. Compound heterozygosity for COL7A1 mutations in twins with dystrophic epidermolysis bullosa: a recessive paternal deletion/insertion mutation and a dominant negative maternal glycine substitution result in a severe phenotype.
Christiano AM; Anton-Lamprecht I; Amano S; Ebschner U; Burgeson RE; Uitto J
Am J Hum Genet; 1996 Apr; 58(4):682-93. PubMed ID: 8644730
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mutations of the type VII collagen gene (COL7A1) in recessive dystrophic epidermolysis bullosa mitis (M-RDEB) from three Korean patients.
Ryoo YW; Kim BC; Lee KS
J Dermatol Sci; 2001 Jun; 26(2):125-32. PubMed ID: 11378329
[TBL] [Abstract][Full Text] [Related]
8. The G2028R glycine substitution mutation in COL7A1 leads to marked inter-familiar clinical heterogeneity in dominant dystrophic epidermolysis bullosa.
Nakamura H; Sawamura D; Goto M; Sato-Matsumura KC; LaDuca J; Lee JY; Masunaga T; Shimizu H
J Dermatol Sci; 2004 May; 34(3):195-200. PubMed ID: 15113589
[TBL] [Abstract][Full Text] [Related]
9. Novel COL7A1 mutations in dystrophic forms of epidermolysis bullosa.
Kon A; Pulkkinen L; Ishida-Yamamoto A; Hashimoto I; Uitto J
J Invest Dermatol; 1998 Sep; 111(3):534-7. PubMed ID: 9740253
[TBL] [Abstract][Full Text] [Related]
10. The clinical spectrum of dystrophic epidermolysis bullosa.
Horn HM; Tidman MJ
Br J Dermatol; 2002 Feb; 146(2):267-74. PubMed ID: 11903238
[TBL] [Abstract][Full Text] [Related]
11. A new glycine substitution mutation in the COL7A1 gene in a Chinese family with dominant dystrophic epidermolysis bullosa.
Zhang XJ; Song YX; Zhang XQ; Yang S; Li M; Li CR; Yang CJ; Yang J
Clin Exp Dermatol; 2003 Jul; 28(4):437-9. PubMed ID: 12823310
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic dilemma of "sporadic" cases of dystrophic epidermolysis bullosa: a new dominant or mitis recessive mutation?
Hashimoto I; Kon A; Tamai K; Uitto J
Exp Dermatol; 1999 Apr; 8(2):140-2. PubMed ID: 10232406
[TBL] [Abstract][Full Text] [Related]
13. A glycine-to-arginine substitution in the triple-helical domain of type VII collagen in a family with dominant dystrophic epidermolysis bullosa pruriginosa.
Lee JY; Pulkkinen L; Liu HS; Chen YF; Uitto J
J Invest Dermatol; 1997 Jun; 108(6):947-9. PubMed ID: 9182828
[TBL] [Abstract][Full Text] [Related]
14. Glycine substitution mutations in the type VII collagen gene (COL7A1) in dystrophic epidermolysis bullosa: implications for genetic counseling.
Kon A; McGrath JA; Pulkkinen L; Nomura K; Nakamura T; Maekawa Y; Christiano AM; Hashimoto I; Uitto J
J Invest Dermatol; 1997 Feb; 108(2):224-8. PubMed ID: 9008239
[TBL] [Abstract][Full Text] [Related]
15. Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants.
Dang N; Klingberg S; Marr P; Murrell DF
J Dermatol Sci; 2007 Jun; 46(3):169-78. PubMed ID: 17425959
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa.
Dang N; Murrell DF
Exp Dermatol; 2008 Jul; 17(7):553-68. PubMed ID: 18558993
[TBL] [Abstract][Full Text] [Related]
17. Glycine substitutions in the triple-helical region of type VII collagen result in a spectrum of dystrophic epidermolysis bullosa phenotypes and patterns of inheritance.
Christiano AM; McGrath JA; Tan KC; Uitto J
Am J Hum Genet; 1996 Apr; 58(4):671-81. PubMed ID: 8644729
[TBL] [Abstract][Full Text] [Related]
18. Compound heterozygosity for a recessive glycine substitution and a splice site mutation in the COL7A1 gene causes an unusually mild form of localized recessive dystrophic epidermolysis bullosa.
Terracina M; Posteraro P; Schubert M; Sonego G; Atzori F; Zambruno G; Bruckner-Tuderman L; Castiglia D
J Invest Dermatol; 1998 Nov; 111(5):744-50. PubMed ID: 9804332
[TBL] [Abstract][Full Text] [Related]
19. A recurrent glycine substitution mutation, G2043R, in the type VII collagen gene (COL7A1) in dominant dystrophic epidermolysis bullosa.
Mellerio JE; Salas-Alanis JC; Talamantes ML; Horn H; Tidman MJ; Ashton GH; Eady RA; McGrath JA
Br J Dermatol; 1998 Oct; 139(4):730-7. PubMed ID: 9892921
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
